Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) is a blank-check company sponsored by Medicus Sciences LLC that completed its initial public offering in 2021, focusing its acquisition mandate on the life sciences and healthcare sector. Its 10-Q quarterly report, filed with the SEC on November 14, 2022 under accession number 0001104659-22-118537, reflects the company's financial and operational position as it remained in the business combination search phase. MSAC is one of several healthcare-focused SPACs active during this period, pursuing merger candidates across biopharma, medtech, and related subsectors. Sign up on SpacDesk for full filings, status tracking, and analytics on MSAC and the broader SPAC universe.